Skip to main content
OpenTrials
Completed

NCT Number: NCT01693289

Study to Compare Between Combimed Metformin-letrozole and Ovarian Drilling in Pcos With Bilateral Ovarian Drilling in Clomiphene-resistant Infertile Women With Polycystic Ovarian Syndrome

the study compare the hormonal-metabolic and reproductive outcome between combined metformin-letrozole and ovarian drilling in clomiphene resistant women with polycystic syndrome

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • polycystic ovary syndrome
  • infertility
  • clomiphene citrate resistance

Exclusion criteria

  • women with other causes of infertility as male factor or tubal factor, those with endocrine disorders as thyroid dysfunction and hyperprolactinemia women who received hormonal treatment or ovulation induction drugs 3 months prior to the study
  • pregnancy during follow up

Treatment and study plan

metformin plus letrozole

Drug

Other names: cidophage plus fumara

ovarian drilling

Procedure

Other names: ovarian dithermy drilling

Primary outcomes

  1. hormonal and metabolic changes

    Time frame: 6 months

Secondary outcomes

  1. reproductive outcome

    Time frame: 6months

Sponsors and collaborators

Lead sponsor

Zagazig University

Other Gov

Registry information

Official study title

Phase 1 Study of Efficacy of Combined Metformin-letrozole in Comparison With Bilateral Ovarian Drilling in Clomiphene-resistant Infertile Women With Polycystic Ovarian Syndrome

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
Sep 26, 2012
Registry last updated
Sep 26, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.